CME.NASDAQCme Group INC

Form 4: CME Group Counsel Marcus Reports Share Vesting, Tax Sales

Sentiment:

Insider Transaction Report


CME Group's Senior Managing Director and General Counsel, Jonathan L. Marcus, reported the vesting of performance shares and subsequent share dispositions for tax obligations.

Summary

  • Jonathan L. Marcus, Sr MD General Counsel of CME Group Inc., reported transactions on March 15, 2026.
  • Marcus acquired 5,270 shares of Class A Common Stock at a price of $311.4 per share due to the vesting of performance shares.
  • These performance shares were granted in 2022 under CME Group's Omnibus Stock Plan, with the number of shares determined by the company's total shareholder return relative to the S&P 500 over a three-year period from January 1, 2023, through December 31, 2025.
  • Marcus disposed of 2,377 shares of Class A Common Stock at $311.4 per share to cover tax withholding obligations related to the performance share award.
  • Additionally, Marcus disposed of 261 shares of Class A Common Stock at $311.4 per share to fulfill tax withholding obligations upon the vesting of restricted stock.
  • Following these transactions, Marcus beneficially owns 10,483 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, as the vesting of performance shares indicates CME Group met its performance targets relative to the S&P 500, reflecting positively on company performance and executive incentives, despite the routine tax-related share sales.

Positives

  • Vesting of 5,270 performance shares indicates the company met performance targets (total shareholder return relative to S&P 500) over the 2023-2025 period.
  • The vesting demonstrates successful execution of long-term incentive plans for executives.

Negatives

  • Disposition of 2,377 shares and 261 shares for tax withholding purposes reduces the direct ownership stake of the executive.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that executive compensation through performance-based equity awards, such as those tied to total shareholder return relative to an index like the S&P 500, is a common practice in the financial services industry. This aligns executive incentives with shareholder value creation, a standard governance practice among publicly traded companies like CME Group.

Comparison to Industry Standards

  • Performance share vesting tied to relative total shareholder return (TSR) against a benchmark like the S&P 500 is a widely adopted best practice in executive compensation across major financial institutions and S&P 500 companies, including peers like Intercontinental Exchange (ICE) and Nasdaq (NDAQ).
  • The practice of executives surrendering shares to cover tax withholding obligations upon equity award vesting is standard across the industry, ensuring compliance with tax laws without requiring cash outlays from the executive.

Stakeholder Impact

  • Shareholders: The vesting of performance shares suggests the company achieved its performance goals, which is generally positive for shareholders. The executive's continued ownership, even after tax sales, aligns interests.
  • Employees: The successful vesting of performance-based awards can serve as a positive signal for other employees regarding the company's performance and the effectiveness of its compensation plans.

Key Dates

DateDescription
2022Performance shares granted under CME Group's Omnibus Stock Plan.
01/01/2023Start of the three-year performance period for performance shares.
12/31/2025End of the three-year performance period for performance shares.
03/15/2026Date of vesting for performance shares and restricted stock, and related share dispositions for tax obligations.
03/17/2026Date the Form 4 was signed.

Recommendation

hold

This Form 4 filing details routine executive compensation events—specifically, the vesting of performance shares and subsequent sales to cover tax obligations. While the vesting indicates the company met its performance targets, which is a positive signal, the transaction itself is not a discretionary open market purchase or sale that would significantly alter the investment thesis. It's an expected part of executive compensation, thus warranting a 'hold' recommendation as it provides no new material information to change a long-term view on the stock.

Keywords

CME Group, CME, Jonathan L. Marcus, Form 4, Insider Trading, Performance Shares, Stock Vesting, Executive Compensation, Share Disposition, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.